Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Aspirin for Preterm Preeclampsia Prevention
NCT05514847Phase 4Active, not recruiting
- Sponsor
- University of Virginia
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in preeclampsia, sponsored by University of Virginia. Started Oct 2022; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05514847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514847.